New determination of cyclandelate in plasma
Andermann, G.; Dietz, M.; Mergel, D.
Journal de Pharmacie de Belgique 34(4): 233-237
1979
ISSN/ISBN: 0047-2166 PMID: 501515 Document Number: 154153
Document emailed within 1 workday
Related Documents
Vecchiet, L.; Dolce, V.; Di Luzio, V.; Fini, F. 1974: Data on the tissular algogenic activity of the plasma after muscular work. 3. Determination of plasma kininogen Bollettino della Societa Italiana di Biologia Sperimentale 49(13): 773-778Ariëns, E.J.; Simonis, A.M. 1980: Determination of drug concentrations in body fluid; possibilities and limitations. II. Determination of plasma levels as a part of individual patient treatment Nederlands Tijdschrift Voor Geneeskunde 124(29): 1201-1212
Fine, E.W. 1971: The use of cyclandelate in chronic brain syndrome with arteriosclerosis Current Therapeutic Research 13(9): 568-574
Timmerman, H. 1984: Modes and mechanisms of action of vasoactive drugs and especially of cyclandelate British Journal of Clinical Practice. Suppl 34: 10-19
Van den Hoven, W.E.; Hall, D.W.; Burns, J.W. 1984: Inhibition of aldose reductase from rat nervous tissue by metabolites of cyclandelate British Journal of Clinical Practice. Suppl 34: 31-33
Dumery, J.P. 1976: Comparative effect of cyclandelate and papaverine on the cerebral circulation of the rabbit La Nouvelle Presse Medicale 5(32): 2081
Cohen, M.L.; Patel, J.K.; Baxter, D.L. 1971: External monitoring and plasma disappearance for the determination of renal function: comparison of effective renal plasma flow and glomerular filtration rate Pediatrics 48(3): 377-392
Kakehi, H.; Murai, M.; Komatsu, H.; Ishimitsu, S.; Okada, S. 1991: Cyclandelate Reference Standard (Control 901) of National Institute of Hygienic Sciences Eisei Shikenjo hokoku. Bulletin of National Institute of Hygienic Sciences 1991(109): 168-170
Klotz, U. 1978: Plasma levels of anticonvulsants. Experiences with routine plasma level determination of 6 different anticonvulsants Fortschritte der Medizin 96(1): 9-13
Gerber, W.D.; Schellenberg, R.; Thom, M.; Haufe, C.; Bölsche, F.; Wedekind, W.; Niederberger, U.; Soyka, D. 1995: Cyclandelate versus propranolol in the prophylaxis of migraine--a double-blind placebo-controlled study Functional Neurology 10(1): 27-35
Li, B.Y.; Tong, L.; Zou, B.T. 1985: TLC determination of theophylline in plasma Yao Xue Xue Bao 20(5): 398-400
Schultzová, A.; Gattnar, O.; Kovácová, D.; Mahrla, Z. 1982: Determination of exaprolol in plasma Ceskoslovenska Farmacie 31(2): 64-66
Nakamura, H. 1988: Determination of plasma lipids and lipoproteins Rinsho Byori. Japanese Journal of Clinical Pathology 36(5): 517-520
Fässler, H.; Duckert, F.; Marbet, G.A. 1977: The determination of plasma proteolytic activity Schweizerische Medizinische Wochenschrift 107(41): 1467
Kotovshchikova, M.A.; Krasko, S.S. 1974: Determination of heparin in blood plasma Laboratornoe Delo 8: 460-463
Cession, G.; Schmitz, G. 1970: Fluorimetric determination of plasma catecholamines Pathologie-Biologie 18(7): 451-460
Liso, V.; Troccoli, G. 1973: Determination of plasma cell esterases Haematologica 58(11): 796-797
Kataoka, S.; Haneda, M.; Morita, K.; Koyama, K.; Fujimaki, M. 1974: Determination of plasma fibrinogen by a TG-meter Rinsho Byori. Japanese Journal of Clinical Pathology 22(10 Suppl): 108
Roots, I. 1986: When is determination of drug concentrations in plasma useful or necessary? Der Internist 27(1): 40-52
Veremeenko, K.N.; Kizim, A.I. 1974: Determination of plasminogen in human blood plasma Voprosy Meditsinskoi Khimii 20(3): 325-328